This Week on NeurologyLive


Here's what is coming soon to NeurologyLive.

Every week, the NeurologyLive staff prepares this preview of what to expect from our coverage. This week on NeurologyLive, there are a number of hot topics that we will be posting throughout the week.

Episode 20 of the "Mind Moments" podcast will go live this Friday, October 23, 2020. It features an interview with Raman Malhotra, MD, associate professor of neurology, Washington University in St. Louis, and board of directors, American Academy of Sleep Medicine. Malhotra will discuss the current state of sleep care, some of the challenges faced by physicians and patients, and what's to come for the field in the near future.

To subscribe on your favorite podcast player, click here.

The first half of a recent conversation with Elias Kouchakji, MD, senior vice president, clinical development, drug safety, and pharmacovigilance, Fibrogen, who sat down to discuss the company’s investigational drug, pamrevlumab, for the treatment of Duchenne muscular dystrophy (DMD) and its upcoming phase 3 trials. Additionally, he detailed the current state of DMD, the treatment landscape within it, and the importance of trying to treat patients earlier in their disease progression.

To check out previous coverage of pamrevlumab, click here.

A conversation with Pavel Klein, MD, director, Mid-Atlantic Epilepsy and Sleep Center, in Bethesda, Maryland, will air on NeurologyLive's segment on the Medical World News channel this Thursday, October 22, 2020. Klein provided perspective on the lasting skepticism from patients regarding changes their treatment strategies during the COVID-19 pandemic, and how these conversations unfolded between patients and their physicians.

To check out our latest conversations with Klein, click here.

In partnership with the Consortium of Multiple Sclerosis Centers (CMSC) and the International Organization for Multiple Sclerosis Nurses (IOMSN), the second of 2 upcoming webcast programs on multiple sclerosis (MS) taking place in October, "Cannabis and MS: Helping Patients Understand Risks and Benefits," will air its second of 3 parts this Wednesday, October 21, at 7PM EDT (the following session will air on the 28th). This progressive webcast series features Allen C. Bowling, MD, PhD, director of the NeuroHealth Institute and clinical professor of neurology at the University of Colorado. Participants will earn 1 CE credit for completing each session.

To register for the webinar, click here.

Related Videos
Michael Levy, MD, PhD
Michael Kaplitt, MD, PhD
Michael Kaplitt, MD, PhD
video 4 - "Amyloid Cascade Hypothesis of Alzheimer’s Disease"
Video 3 - "Amyloid Precursor Protein and Amyloid Beta Species in Alzheimer’s Disease"
© 2024 MJH Life Sciences

All rights reserved.